Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Royal Sense IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2023 Industry: Trading Listed Page

Profile
Issue Size --
Profile
Price Range 68  to  68 per share
Profile
Min Investment ₹68
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Royal Sense Ltd is a leading provider of comprehensive medical solutions, specializing in the supply of high-quality Medical Equipment, Surgical Instruments, Surgical Consumables, Laboratory Equipment, Laboratory Reagents, Medical Disposables, and Diagnostic Kits. With a commitment to excellence, the company ensures the availability of state-of-the-art products to meet the evolving needs of healthcare professionals. Royal Sense Ltd stands out for its dedication to quality assurance, innovation, and customer satisfaction. By offering a diverse range of medical supplies, the company plays a vital role in enhancing healthcare delivery, fostering research, and promoting diagnostic accuracy. With a focus on reliability and efficiency, Royal Sense Ltd continues to be a trusted partner in the medical industry, contributing to advancements in patient care and medical research. Read More

Basic Info

Face Value 10 per share

Price 68  to  68 per share

P/E (x) 5.3

Sales( Cr.) 62

PAT( Cr.) 6

EPS 12.9

Draft Prospectus --

Exchange BSE-SME

Promoter

Company Promoters

Mr. Rishabh Arora

Pre Issue Share Holding 100%

Post Issue Share Holding 66.57%

Listing Details:

Listing Price: 129.2

Listing Gain: 47.37%

Current Price: 130

Gain On Issue: 130 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Mar 12, 2024
Closing Date Mar 14, 2024
Allotment Mar 15, 2024
Refund Mar 18, 2024
Delivery of Shares Mar 18, 2024
Listing Date Mar 19, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 136,000
Retail (Max) 1 2000 136,000
S-HNI (Min) 2 4000 272,000
S-HNI (Max) 7 14000 952,000
B-HNI (Min) 8 16000 1,088,000

Objective of the Issue

1. Working capital requirement 2. Issue Expenses 3. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 725000 7047000 9.7x
Retail 725000 5307000 7.3x
EMP 0 0 0x
Total 1450000 12354000 8.5x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Royal Sense Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 18 62
Other Income 0 0
Total Income 18 62
Total Expenditure 16 53
Operating Profit 2 9
Interest 0 0
Depreciation 0 0
Exceptional Income / Expenses 0 0
Profit Before Tax 2 9
Provision for Tax 1 2
Profit After Tax 2 6
Adjustments 0 0
Profit After Adjustments 2 6
Adjusted Earnings Per Share 3.2 12.7

Royal Sense Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 18 28
Minority's Interest 0 0
Borrowings 0 0
Other Non-Current Liabilities 0 0
Total Current Liabilities 2 8
Total Liabilities 21 36
Fixed Assets 0 2
Other Non-Current Assets 1 1
Total Current Assets 20 33
Total Assets 21 36

Royal Sense Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 9
Cash Flow from Operating Activities -4 1
Cash Flow from Investing Activities -1 -2
Cash Flow from Financing Activities 13 3
Net Cash Inflow / Outflow 9 3
Closing Cash & Cash Equivalent 9 11

Royal Sense Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.24 12.74
CEPS(Rs) 3.26 12.78
DPS(Rs) 0 0
Book NAV/Share(Rs) 37.19 51.47
Core EBITDA Margin(%) 12.73 14.39
EBIT Margin(%) 12.86 14.49
Pre Tax Margin(%) 12.34 14.15
PAT Margin (%) 8.93 10.26
Cash Profit Margin (%) 8.97 10.29
ROA(%) 7.65 22.48
ROE(%) 8.72 28.91
ROCE(%) 11.54 35.21
Receivable days 66 52.55
Inventory Days 85.07 29.27
Payable days 0.65 4.69
PER(x) 33.93 15.41
Price/Book(x) 2.96 3.81
Dividend Yield(%) 0 0
EV/Net Sales(x) 2.63 1.45
EV/Core EBITDA(x) 20.36 9.99
Net Sales Growth(%) 0 246.82
EBIT Growth(%) 0 290.87
PAT Growth(%) 0 298.49
EPS Growth(%) 0 293.03
Debt/Equity(x) 0.09 0.13
Current Ratio(x) 8.66 4.37
Quick Ratio(x) 6.88 3.62
Interest Cover(x) 24.74 42.2
Total Debt/Mcap(x) 0.03 0.03

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 244% 0% 0% 0%
Operating Profit CAGR 350% 0% 0% 0%
PAT CAGR 200% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -47% NA% NA% NA%
ROE Average 29% 19% 19% 19%
ROCE Average 35% 23% 23% 23%

Company Contact Information

Royal Sense Ltd.

C-7, Phase-3 Badli Industrial Area Badli, North West Delhi

IPO Lead Manager(s)

Royal Sense Ltd.

Expert Global Consultants Pvt Ltd.

Registrar Info

Royal Sense Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!